Search Results

There are 6811427 results for: content related to: Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

  1. The effect  of  1  month  of  therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study

    Liver International

    Volume 29, Issue 2, February 2009, Pages: 169–174, Puneeta Tandon, Ross T. Tsuyuki, Lesley Mitchell, Michael Hoskinson, Mang M. Ma, Winnie W. Wong, Andrew L. Mason, Klaus Gutfreund and Vincent G. Bain

    Article first published online : 20 MAY 2008, DOI: 10.1111/j.1478-3231.2008.01778.x

  2. You have free access to this content
    Current treatment strategies for hepatorenal syndrome

    Clinical Liver Disease

    Volume 2, Issue 3, June 2013, Pages: 136–139, Elsa Solà, Mónica Guevara and Pere Ginès

    Article first published online : 21 JUN 2013, DOI: 10.1002/cld.209

  3. You have free access to this content
    Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

    Hepatology

    Volume 29, Issue 6, June 1999, Pages: 1690–1697, Paolo Angeli, Roberta Volpin, Giorgio Gerunda, Raffaella Craighero, Paola Roner, Roberto Merenda, Piero Amodio, Antonietta Sticca, Lorenza Caregaro, Alvise Maffei-Faccioli and Angelo Gatta

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510290629

  4. Hepatorenal syndrome: The last pieces of the puzzle or not yet?

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 352–354, Isabel Graupera and Pere Ginès

    Article first published online : 29 MAY 2015, DOI: 10.1002/hep.27829

  5. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study

    Liver International

    Volume 28, Issue 7, August 2008, Pages: 1019–1025, Beate Appenrodt, Andrea Wolf, Frank Grünhage, Jonel Trebicka, Michael Schepke, Christian Rabe, Frank Lammert, Tilman Sauerbruch and J. Heller

    Article first published online : 11 APR 2008, DOI: 10.1111/j.1478-3231.2008.01734.x

  6. You have free access to this content
    Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

    Hepatology

    Volume 28, Issue 4, October 1998, Pages: 937–943, Paolo Angeli, Roberta Volpin, Donatella Piovan, Andrea Bortoluzzi, Raffaella Craighero, Stefania Bottaro, Gian Franco Finucci, Edoardo Casiglia, Antonietta Sticca, Renzo De Toni, Lucia Pavan and A. Gatta

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510280407

  7. You have free access to this content
    The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond

    Hepatology

    Volume 43, Issue 3, March 2006, Pages: 385–394, Richard Moreau and Didier Lebrec

    Article first published online : 22 FEB 2006, DOI: 10.1002/hep.21094

  8. Treatment of Hepatorenal Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1196–1211, Tyree H. Kiser, Robert MacLaren and Douglas N. Fish

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1196

  9. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 567–574, Marta Cavallin, Patrick S. Kamath, Manuela Merli, Silvano Fasolato, Pierluigi Toniutto, Francesco Salerno, Mauro Bernardi, Roberto Giulio Romanelli, Cosimo Colletta, Freddy Salinas, Antonio Di Giacomo, Lorenzo Ridola, Ezio Fornasiere, Paolo Caraceni, Filippo Morando, Salvatore Piano, Angelo Gatta, Paolo Angeli and for the Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome

    Article first published online : 13 FEB 2015, DOI: 10.1002/hep.27709

  10. Stereoselective determination of midodrine and desglymidodrine in culture medium: Application to a biotransformation study employing endophytic fungi

    ELECTROPHORESIS

    Volume 31, Issue 9, May 2010, Pages: 1521–1528, Thiago Barth, Mônica Tallarico Pupo, Keyller Bastos Borges, Laura Tiemi Okano and Pierina Sueli Bonato

    Article first published online : 6 APR 2010, DOI: 10.1002/elps.200900685

  11. You have free access to this content
    Poster Session 1: Ascites, Renal Dysfunction, and Hepatorenal Syndrome

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 345A–362A,

    Article first published online : 7 OCT 2015, DOI: 10.1002/hep.28209

  12. Agents for the treatment of portal hypertension

    Pocket Guide to Gastrointestinal Drugs

    Karen L. Krok, Andrés Cárdenas, Pages: 165–178, 2014

    Published Online : 10 JAN 2014, DOI: 10.1002/9781118481530.ch12

  13. Midodrine for the weaning of vasopressor infusions

    Journal of Clinical Pharmacy and Therapeutics

    L. B. Poveromo, E. L. Michalets and S. E. Sutherland

    Article first published online : 4 MAR 2016, DOI: 10.1111/jcpt.12375

  14. Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotension

    Clinical Transplantation

    Volume 14, Issue 1, February 2000, Pages: 42–47, George C Hurst, Kenneth T Somerville, Rita R Alloway, A Osama Gaber and Robert J Stratta

    Article first published online : 25 DEC 2001, DOI: 10.1034/j.1399-0012.2000.140108.x

  15. You have free access to this content
    The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 1044–1050, V. L. Misra, R. Vuppalanchi, D. Jones, M. Hamman, P. Y. Kwo, C. Kahi and N. Chalasani

    Article first published online : 4 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04426.x

  16. Chiral investigation of midodrine, a long-acting α-adrenergic stimulating agent

    Chirality

    Volume 16, Issue 6, 2004, Pages: 356–362, M.G. Quaglia, A. Farina, M. Palmery, N. Desideri, E. Donati, E. Bossù and S. Strano

    Article first published online : 20 MAY 2004, DOI: 10.1002/chir.20041

  17. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension – midodrine and dihydroergotamine

    Fundamental & Clinical Pharmacology

    Volume 21, Issue 1, February 2007, Pages: 45–53, Géraldine Jourdan, Patrick Verwaerde, Atul Pathak, Marie-Antoinette Tran, Jean-Louis Montastruc and Jean-Michel Senard

    Article first published online : 18 DEC 2006, DOI: 10.1111/j.1472-8206.2006.00450.x

  18. You have free access to this content
    Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis

    Journal of Digestive Diseases

    Volume 17, Issue 1, January 2016, Pages: 11–19, Ting Ting Guo, Yue Yang, Yang Song, Yu Ren, Zhi Xin Liu and Gang Cheng

    Article first published online : 25 FEB 2016, DOI: 10.1111/1751-2980.12304

  19. Lecture: Hepatorenal Syndrome: Current Concepts

    Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop

    Andrés Cárdenas, Pere Ginés, Pages: 201–216, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470988831.ch8

  20. You have free access to this content
    Acute kidney injury in cirrhosis

    Hepatology

    Volume 48, Issue 6, December 2008, Pages: 2064–2077, Guadalupe Garcia-Tsao, Chirag R. Parikh and Antonella Viola

    Article first published online : 2 SEP 2008, DOI: 10.1002/hep.22605